Endocrine autoimmune diseases;Auto-immuunziekten van endocriene organen

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 4, 2006, Pages 275-281

  Batstra, M R ^a,c   Drexhage, H A ^b  

^a Afdeling Medische Laboratoria   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Addison's disease; Autoantibodies; Autoimmune polyendocrinopathies; Autoimmune thyroiditis; Diabetes mellitus type 1; Pernicious anemia; Premature ovarian failure

Indexed keywords

AUTOANTIBODY;

ADDISON DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; DISEASE ACTIVITY; ENDOCRINE DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PERNICIOUS ANEMIA; PREMATURE OVARIAN FAILURE; REVIEW; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 37049006323     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Rose NR and Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunology Today 1993; 14: 426-430.
2. Peter JB, Shoenfeld Y (eds). Autoantibodies. Elsevier Science BV Amsterdam 1996.
3. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26: 260-267.
4. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature. 2005; 435: 584-589.
5. Anderson MS. Autoimmune endocrine disease. Curr Opin Immunol 2002; 14: 760-764.
6. Kyewski B, Derbinski J. Self-representation in the thymus: an extended view. Nat Rev Immunol 2004; 4: 688-698.
7. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298: 1395-1401.
8. Many MC, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef JF. Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis. J Endocrinol 1995; 147: 311-320.
9. Stassi G, De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002; 2: 195-204.
10. Roberts CG, Ladenson PW. Hypothyroidism. Lancet 2004; 363: 793-803.
11. Ginsberg J. Diagnosis and management of Graves' disease CMAJ 2003; 168: 575-85.
12. Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D. Congenital hyperthyroidism: the fetus as a patient. Horm Res 2006; 65: 235-242.
13. Wiersinga WM, Krenning EP, red. Schildklierziekten. Samsom Stafleu, Alphen a/d Rijn 1988.
14. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK The Belgian diabetes registry. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. Diabetes Care 1997; 20: 1556-1561.
15. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001; 345: 1036-1040.
16. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, Wickramasinghe S, Colle E, Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289-92.
17. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002; 51: 1383-1390.
18. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 2004; 328: 750-754.
19. Batstra MR, Aanstoot HJ, Herbrink P. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies. Clin Lab 2001; 47: 497-507.
20. Akerblom HK, Virtanen SM, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hamalainen AM, Paronen J, Riikjarv MA, Ormisson A, Ludvigsson J, Dosch HM, Hakulinen T, Knip M; National TRIGR Study Groups. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia 2005; 48: 829-837.
21. Daneman D. Type 1 diabetes. Lancet 2006; 367: 847-858.
22. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 36: 1881-1893.
23. Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: results and developments. Trends Endocrinol Metab 2000; 11: 285-90.
24. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004; 10: 163-175.
25. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997; 337: 1441-1448.